Evidence map›Paper›PMID 42797558›Full record

ArticleVaccines2026

An Expert Perspective on a New Recombinant Pertussis-Only Vaccine and Its Potential Clinical and Programmatic Advantages in Australia, New Zealand, and Beyond.

Peter McIntyre, Anita H J van den Biggelaar, Frank Beard, Mary Nowlan, Annette K Regan, Rodney Pearce, Terry Nolan, Catherine Hughes, Peter Richmond

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Peter McIntyreDepartment of Women's and Children's Health, School of Medicine, University of Otago, 362 Leith Street, North Dunedin, Dunedin 9016, New Zealand.
Anita H J van den BiggelaarWesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, 15 Hospital Avenue, Nedlands, WA 6009, Australia.ORCID 0000-0002-3323-7261
Frank BeardSchool of Public Health, Faculty of Medicine and Health, The University of Sydney, 1 Western Avenue, Camperdown, NSW 2050, Australia.ORCID 0000-0002-9151-4781
Mary NowlanImmunisation Advisory Centre, Department of General Practice and Health Care, The University of Auckland, Private Bag 92019, Victoria St West, Auckland 1142, New Zealand.ORCID 0000-0001-8691-4150
Annette K ReganDepartment of Epidemiology, Fielding School of Public Health, University of California Los Angeles, 650 Charles E Young Dr S, Los Angeles, CA 90095, USA.
Rodney PearceMedical HQ Glynde, 127 Glynburn Road, Adelaide, SA 5070, Australia.
Terry NolanPeter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC 3010, Australia.ORCID 0000-0001-6018-3863
Catherine HughesImmunisation Foundation of Australia, P.O. Box 186, Bassendean, WA 6935, Australia.
Peter RichmondWesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute Australia, 15 Hospital Avenue, Nedlands, WA 6009, Australia.ORCID 0000-0001-7562-7228

Funding

Technovalia
6 · The paper itself

Abstract

Despite high childhood coverage and booster doses of pertussis vaccination across the life course, pertussis (whooping cough) outbreaks continue to occur, including in Australia and New Zealand. In January 2026, the European Medicines Agency (EMA) granted marketing authorisation to a new pertussis-only booster vaccine (VacPertagen

Indexed as

boosterpertussispertussis-onlyrecombinantvaccination

Identifiers

PMID42797558
PMCPMC13611157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.